Bloomberg Market Wrap 1/15: Financials, S&P 500 and Edwards Life

The video discusses the performance of financials during the bank earnings season, highlighting Citigroup, JP Morgan, and Wells Fargo. It analyzes the S&P 500's movement around the 2600 level, indicating a potential shift in market control from bears to bulls. Additionally, it covers Edward Life Sciences' stock rise following a patent dispute settlement with Boston Scientific, impacting the healthcare sector positively.

Which financial institution was mentioned as having a headline miss but still saw a stock boost due to forward guidance?

• Goldman Sachs

• Wells Fargo

• Citigroup

• Bank of America

What was the significance of the 2600 level on the S&P 500 index?

• It was a new all-time high.

• It was a point of support and resistance.

• It indicated a market crash.

• It marked the beginning of a bull market.

What was the main reason for Edward Life Sciences' stock rise?

• Increase in global sales

• Acquisition of a competitor

• Settlement of a patent dispute

• A new product launch

Which company was Edward Life Sciences' main rival in the patent dispute?

• Abbott Laboratories

• Boston Scientific

• Medtronic

• Johnson & Johnson

What type of product was at the center of the patent dispute between Edward Life Sciences and its rival?

• Artificial heart valves

• Stents

• Defibrillators

• Pacemakers